CLINICAL_TRIALS
trial_result
· 2023-08-01
Clinical Trial Update: Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion [Phase 4]
Summary
A Phase 4 trial evaluated adding buprenorphine to a paracervical block to control pain during osmotic dilator insertion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Procedural Pain, Buprenorphine | Phase 4 | Status: COMPLETED | Results posted: 2023-08-01